| Code | 9931C | ||||||||||
| MA number | 64/0423/18-S | ||||||||||
| Product Form: | int opo 1x5 ml (fľ.LDPE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Olikla s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 64 - OPHTHALMOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | bottle LDPE | ||||||||||
| Route of admin.: | Ocular use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 18.12.2018 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Moxifloxacin Olikla 5 mg ml_int opo_10.2023.pdf
|
| SPC: |
SPC_Moxifloxacin Olikla 5 mg ml_int opo_10.2023.docx
|
| Safety feature | Yes |
| Data update: | 25.10.2023 |
